KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to 0.73.

  • Vertex Pharmaceuticals' Equity Ratio fell 4.54% to 0.73 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.73, marking a year-over-year decrease of 4.54%. This contributed to the annual value of 0.73 for FY2025, which is 4.54% down from last year.
  • Vertex Pharmaceuticals' Equity Ratio amounted to 0.73 in Q4 2025, which was down 4.54% from 0.7 recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Equity Ratio registered a high of 0.78 during Q3 2022, and its lowest value of 0.7 during Q3 2025.
  • In the last 5 years, Vertex Pharmaceuticals' Equity Ratio had a median value of 0.75 in 2021 and averaged 0.75.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 494.9% in 2021, then plummeted by 752.84% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Equity Ratio (Quarter) stood at 0.75 in 2021, then rose by 1.94% to 0.77 in 2022, then rose by 0.9% to 0.77 in 2023, then dropped by 5.84% to 0.73 in 2024, then fell by 0.05% to 0.73 in 2025.
  • Its Equity Ratio was 0.73 in Q4 2025, compared to 0.7 in Q3 2025 and 0.71 in Q2 2025.